|
MediciNova, Zhejiang Announce Execution Of China JV To Develop Astma Drug
RTT News (RTTNews) – MediciNova Inc. (MNOV: News ) and Zhejiang Medicine Co., Ltd. Wednesday announced the execution of an agreement for the formation of a Joint Venture to develop and commercialize MediciNova's asthma drug MN-221 in China. … Chinese Joint Venture Completed |
View full post on asthma – Google News